<DOC>
	<DOCNO>NCT00714545</DOCNO>
	<brief_summary>This study prospective study patient treat Scripps Clinic intracoronary brachytherapy recurrent restenosis within drug elute stent .</brief_summary>
	<brief_title>SCRIPPS V : Intracoronary Brachytherapy Recurrent Restenosis After Multiple Drug-Eluting Stents</brief_title>
	<detailed_description>This investigator-initiated protocol examine effectiveness intracoronary brachytherapy use Novoste beta-emitting catheter recurrent stenosis treatment multiple drug-eluting stent . While intracoronary brachytherapy use purpose clinician time , data support clinical decision-making lacking . Currently , cardiologists find restenosis implant drug-eluting stent , often place stent elutes different drug within stent . If patient present restenosis segment already treat sirolimus paclitaxel-eluting stent , option limit . Intracoronary brachytherapy often use scenario , efficacy approach well study . The investigator recently review clinical outcome five patient underwent intracoronary radiation drug-eluting stent . They discover one episode target vessel revascularization episode stent thrombosis . While sample small , investigator believe prospective study provide important information regard approach .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<criteria>1 . Age 18 year old . 2 . Eligible percutaneous coronary intervention . 3 . Target lesion recurrent restenosis ( &gt; 50 % visual estimate ) previously treat 2 combination DES stent . 4 . Signs symptom ischemia attributable target lesion , stenosis &gt; 50 % visual estimation lesion angiography . 5 . Target lesion locate within native coronary artery bypass graft . 6 . Be reliable , cooperative willing comply protocolspecified procedure followup . 7 . Able understand sign inform consent . 1 . Confirmed pregnancy time index PCI . 2 . Has know allergy aspirin , clopidogrel ( Plavix ® ) ticlopidine ( Ticlid ® ) . 3 . Has know allergy contraindication heparin Bivalirudin ( Angiomax ® ) . 4 . Has significant medical condition investigator 's opinion may interfere patient 's optimal participation study . 5 . Any serious disease condition life expectancy le 1 year . 6 . Unsuccessful coronary revascularization procedure ( residual stenosis &gt; 30 % ) . 7 . Angiographic evidence thrombus . 8 . No Previous intracoronary radiation target artery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Coronary Restenosis</keyword>
	<keyword>Brachytherapy</keyword>
</DOC>